TNC and neoplasm: Interestingly, Chen B. et al. (2016) have demonstrated the effect of Tenascin C, a tumor-specific ECM targeted FHKHKSPALSPVGGG peptide-coated liposomal delivery of Navitoclax (NAV), a targeted high-affinity small molecule for priming tumor microenvironment.